Company / SG&A per Share
Eton Pharmaceuticals, Inc. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.74
FY2025
5-year range
$0.31 / $0.74
FY2021-FY2025
Trend
+0.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has increased for 6 consecutive years, from $0.18 in FY2019 to $0.74 in FY2025.
Based on SEC 10-K filings.
0.74 in FY2025 with a 5-year CAGR of +22.9%.
Increased from $0.59 to $0.74 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +12.9%
- 5-Year CAGR
- +22.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Eton Pharmaceuticals, Inc.'s sg&a per share has grown for 6 consecutive years.
- In FY2025, sg&a per share increased 0.5% year-over-year.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.74 | +0.5% |
| FY2024 | $0.73 | +24.9% |
| FY2023 | $0.59 | +14.6% |
| FY2022 | $0.51 | +64.9% |
| FY2021 | $0.31 | +18.3% |
| FY2020 | $0.26 | +43.6% |
| FY2019 | $0.18 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026